<DOC>
	<DOCNO>NCT02823548</DOCNO>
	<brief_summary>PICASSO design demonstrate combination therapy CS/GH superior efficacy compare placebo pain reduction ( average score reduction Huskisson 's 0 100 mm Visual Analogue Scale ) baseline 6 month treatment patient symptomatic hand osteoarthritis .</brief_summary>
	<brief_title>Primary Care Study With Chondroitin Sulfate Glucosamine Hydrochloride Hand Osteoarhritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>1 . Men woman ≥ 40 year age ; 2 . Clinical diagnosis hand osteoarthritis accord ACR criterion ; 3 . Patients pain deformity least 2 interphalangeal joint study hand ; 4 . Patients simple standard anteroposterior Xray hand obtain within 6 month prior screen ; 5 . Patients radiological evidence hand osteoarthritis grade 23 accord KellgrenLawrence radiological scale . Patients must present radiological involvement least 2 interphalangeal joint study hand , without rhizarthrosis ; 6 . Patients pain studied hand day month prior screen visit ; 7 . Patients hand pain ≥ 45 mm Huskisson 's Visual Analogue Scale screen visit ; 8 . Patients present Functional Index Hand Osteoarthritis ( FIHOA ) score ≥ 6 screen visit ; 9 . Women childbearing age ( woman whose last menstrual period one year study enrolment tubal ligation hysterectomy perform exclude ) must obtain negative result pregnancy test conduct screen phase must agree use medically acceptable contraceptive method throughout duration study . Men participate study must also agree use medically acceptable contraceptive intercourse woman childbearing age ; 10 . Patients must sufficient level cognition allow proper communication cooperation test examination require protocol ; 11 . Patients clearly inform method limitation study agree sign inform consent form prior conduct study procedure ; 12 . Patients participate another clinical trial ; 13 . Patients agree respect protocol , attend visit relate study ; 1 . Patients isolated unilateral bilateral rhizarthrosis and/or radiological evidence presence erosive hand osteoarthritis ( one erosive joint lead classify patient erosive ) . 2 . Patients know allergy CS GH ; 3 . Patients seafood allergy ; 4 . Patients history intolerance paracetamol ; 5 . Patients active malignancy type history malignancy last five year ; 6 . Patients , investigator 's judgement , significant clinical alteration physical examination laboratory parameter ; 7 . History condition , investigator 's opinion , could lead misinterpretation study result could pose additional risk patient ; 8 . Concurrent articular rheumatism ( history and/or current presence sign ) could give rise erroneous interpretation efficacy pain interfere assessment , carpal tunnel syndrome , Guyon 's canal syndrome ( involvement cubital nervous ) , flexor tenosynovitis , trigger finger , chondrocalcinosis , , aseptic osteonecrosis , gout , septic arthritis , ochronosis , acromegaly , haemochromatosis , Wilson 's disease , osteochondromatosis , rheumatoid arthritis , ankilosing spondylitis , psoriasis , inflammatory bowel disease , connective tissue disease , vasculitis , diabetic neuropathy , posttraumatic osteoarthritis finger ; 9 . Pain part body intense hand , could interfere assessment joint index ; 10 . Patients fibromyalgia ; 11 . Patients surgery schedule clinical trial period ; 12 . Patients important disease process , psychological psychiatric disorder drug consumption , investigator 's opinion , likely alter progress osteoarthritis patient 's ability complete study ; 13 . Patients poorly control diabetes mellitus define level haemoglobin A1c &gt; 8 % ; 14 . Patients poorly control hypertension ( sustain systolic blood pressure ≥160 mm Hg sustain diastolic blood pressure ≥100 mm Hg ) ; 15 . Patients active acute chronic infection require antibiotic treatment , serious fungal viral infection ( example , hepatitis , herpes zoster , HIV positive ) ; 16 . Patients chronic liver kidney disease , define AST ALT level &gt; 2 time upper limit normal ( ULN ) blood urea nitrogen ( BUN ) serum creatinine level &gt; 2 time ULN inclusion visit ; 17 . Patients history alcohol drug consumption abuse last 3 year ; 18 . Patients receive investigational drug 30 day prior screen visit ; 19 . Women breastfeed ; Treatmentrelated exclusion criterion Patients receive lithium carbonate , phenytoin anticoagulant , warfarin ( exception ASA maximum daily dose 100 mg ) ; Patients complete follow washout period treatment prior inclusion visit : 6 month intraarticular hyaluronic acid hand ; 3 month articular lavage , glucosamine , CS , diacerein nutraceuticals ; 1 month corticosteroid ( oral , injectable ) , topical corticosteroid hand , medicinal plant homoeopathic product indicate hand OA ; 1 week analgesic cream gel hand ( i.e . Capsaicin ) , oral analgesic , include opioids tramadol codeine ; oral topic NSAIDs oral selective COX2 inhibitor ( Coxibs ) ; Patients allow continue ASA treatment ( maximum daily dose 100 mg ) cardiovascular event prevention ; 1 week physical therapy acupuncture , electromagnetic field , physiotherapy paraffin bath .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>